{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:04:22Z","timestamp":1784653462210,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/10599-3"],"award-info":[{"award-number":["2021\/10599-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/10599-3"],"award-info":[{"award-number":["2021\/10599-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11046-024-00867-w","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:03:28Z","timestamp":1719547408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Systematic Review of Candidemia in Brazil: Unlocking Historical Trends and Challenges in Conducting Surveys in Middle-Income Countries"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-5512","authenticated-orcid":false,"given":"Fl\u00e1vio Guinsburg","family":"Hamburger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0913-768X","authenticated-orcid":false,"given":"Ana Cristina","family":"Gales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-8491","authenticated-orcid":false,"given":"Arnaldo Lopes","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"issue":"1","key":"867_CR1","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4(1):18026. https:\/\/doi.org\/10.1038\/nrdp.2018.26.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"867_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.idc.2021.03.007","volume":"35","author":"TP McCarty","year":"2021","unstructured":"McCarty TP, White CM, Pappas PG. Candidemia and Invasive Candidiasis. Infect Dis Clin North Am. 2021;35(2):389\u2013413. https:\/\/doi.org\/10.1016\/j.idc.2021.03.007.","journal-title":"Infect Dis Clin North Am"},{"key":"867_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix131","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF. Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017. https:\/\/doi.org\/10.1093\/infdis\/jix131.","journal-title":"J Infect Dis"},{"issue":"4","key":"867_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/jof9040468","volume":"9","author":"C Agnelli","year":"2023","unstructured":"Agnelli C, Guimar\u00e3es T, Sukiennik T, Lima PRP, Salles MJ, Breda GL, et al. Prognostic trends and current challenges in candidemia: a comparative analysis of two multicenter cohorts within the past decade. J Fungi. 2023;9(4):468. https:\/\/doi.org\/10.3390\/jof9040468.","journal-title":"J Fungi"},{"key":"867_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad139","author":"A Soriano","year":"2023","unstructured":"Soriano A, Honore PM, Puerta-Alcalde P, Garcia-Vidal C, Pagotto A, Gon\u00e7alves-Bradley DC, et al. Invasive candidiasis: current clinical challenges and unmet needs in adult populations. J Antimicrob Chemother. 2023. https:\/\/doi.org\/10.1093\/jac\/dkad139.","journal-title":"J Antimicrob Chemother"},{"key":"867_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy358","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997\u20132016. Open Forum Infect. 2019. https:\/\/doi.org\/10.1093\/ofid\/ofy358.","journal-title":"Open Forum Infect"},{"key":"867_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac071","author":"T Kajihara","year":"2022","unstructured":"Kajihara T, Yahara K, Nagi M, Kitamura N, Hirabayashi A, Hosaka Y, et al. Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010\u20132019: a retrospective observational study based on national surveillance data. Med Mycol. 2022. https:\/\/doi.org\/10.1093\/mmy\/myac071.","journal-title":"Med Mycol"},{"issue":"6","key":"867_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/QCO.0000000000000411","volume":"30","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, Junior JNA, Guinea J. Emerging multidrug-resistant Candida species. Curr Opin Infect Dis. 2017;30(6):528\u201338. https:\/\/doi.org\/10.1097\/QCO.0000000000000411.","journal-title":"Curr Opin Infect Dis"},{"key":"867_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fcimb.2020.00166","volume":"10","author":"J Guinea","year":"2020","unstructured":"Guinea J, Arendrup MC, Canton R, Canton E, Garcia-Rodriguez J, Gomez A, et al. Genotyping reveals high clonal diversity and widespread genotypes of Candida causing candidemia at distant geographical areas. Front Cell Infect Microbiol. 2020;10:166. https:\/\/doi.org\/10.3389\/fcimb.2020.00166.","journal-title":"Front Cell Infect Microbiol"},{"key":"867_CR10","volume-title":"WHO fungal priority pathogens list to guide research, development and public health action [Eletronic]","author":"WH Organization","year":"2022","unstructured":"Organization WH. WHO fungal priority pathogens list to guide research, development and public health action [Eletronic]. Geneva: World Health Organization; 2022."},{"issue":"1","key":"867_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/13693786.2012.698024","volume":"51","author":"AL Colombo","year":"2013","unstructured":"Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013;51(1):38\u201344. https:\/\/doi.org\/10.3109\/13693786.2012.698024.","journal-title":"Med Mycol"},{"issue":"3","key":"867_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/13693786.2012.708107","volume":"51","author":"ML Moretti","year":"2013","unstructured":"Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, et al. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol. 2013;51(3):225\u201330. https:\/\/doi.org\/10.3109\/13693786.2012.708107.","journal-title":"Med Mycol"},{"issue":"6","key":"867_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/qco.0000000000000411","volume":"30","author":"AL Colombo","year":"2017","unstructured":"Colombo AL, J\u00fanior JNdA, Guinea J. Emerging multidrug-resistant Candida species. Curr Opin Infect Dis. 2017;30(6):528\u201338. https:\/\/doi.org\/10.1097\/qco.0000000000000411.","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"867_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028.","journal-title":"Clin Microbiol Infect"},{"key":"867_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-5247(23)00067-8","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia F, De Almeida J\u00fanior JN, Ilkit M, Lombardi L, Perry AM, Gao M, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. Lan Microbe. 2023. https:\/\/doi.org\/10.1016\/s2666-5247(23)00067-8.","journal-title":"Lan Microbe"},{"issue":"2","key":"867_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/jof9020207","volume":"9","author":"B Spruijtenburg","year":"2023","unstructured":"Spruijtenburg B, Baqueiro CCSZ, Colombo AL, Meijer EFJ, De Almeida JN, Berrio I, et al. Short tandem repeat genotyping and antifungal susceptibility testing of Latin American Candida tropicalis isolates. J Fungi. 2023;9(2):207. https:\/\/doi.org\/10.3390\/jof9020207.","journal-title":"J Fungi"},{"issue":"3","key":"867_CR17","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40121-022-00625-9","volume":"11","author":"F Briano","year":"2022","unstructured":"Briano F, Magnasco L, Sepulcri C, Dettori S, Dentone C, Mikulska M, et al. Candida auris Candidemia in critically Ill, colonized patients: cumulative incidence and risk factors. Infect Dis Ther. 2022;11(3):1149\u201360. https:\/\/doi.org\/10.1007\/s40121-022-00625-9.","journal-title":"Infect Dis Ther"},{"key":"867_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.micpath.2018.09.014","volume":"125","author":"J De C\u00e1ssia Orlandi Sardi","year":"2018","unstructured":"De C\u00e1ssia Orlandi Sardi J, Silva DR, Soares Mendes-Giannini MJ, Rosalen PL. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microbial Pathog. 2018;125:116\u201321. https:\/\/doi.org\/10.1016\/j.micpath.2018.09.014.","journal-title":"Microbial Pathog"},{"issue":"2","key":"867_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2022.101248","volume":"32","author":"G Desoubeaux","year":"2022","unstructured":"Desoubeaux G, Coste AT, Imbert C, Hennequin C. Overview about Candida auris: What\u2019s up 12 years after its first description? J Med Mycol. 2022;32(2): 101248. https:\/\/doi.org\/10.1016\/j.mycmed.2022.101248.","journal-title":"J Med Mycol"},{"key":"867_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100250","volume":"11","author":"JH Ellwanger","year":"2022","unstructured":"Ellwanger JH, Chies JAB. Candida auris emergence as a consequence of climate change: impacts on Americas and the need to contain greenhouse gas emissions. Lan Reg Health Am. 2022;11: 100250. https:\/\/doi.org\/10.1016\/j.lana.2022.100250.","journal-title":"Lan Reg Health Am"},{"issue":"2","key":"867_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3947\/ic.2022.0008","volume":"54","author":"A Sanyaolu","year":"2022","unstructured":"Sanyaolu A, Okorie C, Marinkovic A, Abbasi AF, Prakash S, Mangat J, et al. Candida auris: an overview of the emerging drug-resistant fungal infection. Infect Chemother. 2022;54(2):236. https:\/\/doi.org\/10.3947\/ic.2022.0008.","journal-title":"Infect Chemother"},{"key":"867_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04270-z","author":"A-L Bienvenu","year":"2022","unstructured":"Bienvenu A-L, Bestion A, Pradat P, Richard J-C, Argaud L, Guichon C, et al. Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis. Crit Care. 2022. https:\/\/doi.org\/10.1186\/s13054-022-04270-z.","journal-title":"Crit Care"},{"key":"867_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jof7030220","author":"JN de Almeida Jr","year":"2021","unstructured":"de Almeida JN Jr, Francisco EC, Hagen F, Brandao IB, Pereira FM, Presta Dias PH, et al. Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit. J Fungi. 2021. https:\/\/doi.org\/10.3390\/jof7030220.","journal-title":"J Fungi"},{"key":"867_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-022-01085-z","author":"RM Kariyawasam","year":"2022","unstructured":"Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019\u2013June 2021). Antimicrob Resis Infect Control. 2022. https:\/\/doi.org\/10.1186\/s13756-022-01085-z.","journal-title":"Antimicrob Resis Infect Control."},{"issue":"9","key":"867_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/myc.13320","volume":"64","author":"J De Nobrega Almeida","year":"2021","unstructured":"De Nobrega Almeida J, Brand\u00e3o IB, Francisco EC, De Almeida SLR, De Oliveira Dias P, Pereira FM, et al. Axillary digital thermometers uplifted a multidrug-susceptible Candida auris outbreak among COVID-19 patients in Brazil. Mycoses. 2021;64(9):1062\u201372. https:\/\/doi.org\/10.1111\/myc.13320.","journal-title":"Mycoses"},{"issue":"2","key":"867_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/myc.13225","volume":"64","author":"M Nucci","year":"2021","unstructured":"Nucci M, Barreiros G, Guimar\u00e3es LF, Deriquehem VAS, Casti\u00f1eiras AC, Nou\u00e9r SA. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses. 2021;64(2):152\u20136. https:\/\/doi.org\/10.1111\/myc.13225.","journal-title":"Mycoses"},{"key":"867_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac028","author":"MA Pfaller","year":"2022","unstructured":"Pfaller MA, Carvalhaes CG, Devries S, Rhomberg PR, Castanheira M. Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections. Med Mycol. 2022. https:\/\/doi.org\/10.1093\/mmy\/myac028.","journal-title":"Med Mycol"},{"issue":"4","key":"867_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/myc.12890","volume":"62","author":"DR Falci","year":"2019","unstructured":"Falci DR, Pasqualotto AC. Clinical mycology in Latin America and the Caribbean: a snapshot of diagnostic and therapeutic capabilities. Mycoses. 2019;62(4):368\u201373. https:\/\/doi.org\/10.1111\/myc.12890.","journal-title":"Mycoses"},{"issue":"3","key":"867_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bjid.2019.05.004","volume":"23","author":"AC Pasqualotto","year":"2019","unstructured":"Pasqualotto AC, Sukiennik TCT, Meis JF. Brazil is so far free from Candida auris. Are we missing something? Braz J Infect Dis. 2019;23(3):149\u201350. https:\/\/doi.org\/10.1016\/j.bjid.2019.05.004.","journal-title":"Braz J Infect Dis"},{"key":"867_CR30","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2023.471","author":"F Riera","year":"2023","unstructured":"Riera F, Cortes Luna J, Rabagliatti R, Scapellato P, Caeiro JP, Chaves Magri MM, et al. Antifungal stewardship: the Latin American experience. Antimicrob Steward Healthc Epidemiol. 2023. https:\/\/doi.org\/10.1017\/ash.2023.471.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"867_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"867_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01811-20.10.1128\/jcm.01811-20","author":"M Borman Andrew","year":"2021","unstructured":"Borman Andrew M, Johnson Elizabeth M. Name changes for fungi of medical importance, 2018\u20132019. J Clin Microbiol. 2021. https:\/\/doi.org\/10.1128\/jcm.01811-20.10.1128\/jcm.01811-20.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"867_CR33","doi-asserted-by":"publisher","first-page":"ofac559","DOI":"10.1093\/ofid\/ofac559","volume":"10","author":"SE Kidd","year":"2023","unstructured":"Kidd SE, Abdolrasouli A, Hagen F. Fungal nomenclature: managing change is the name of the game. Open Forum Infect Dis. 2023;10(1):ofac559. https:\/\/doi.org\/10.1093\/ofid\/ofac559.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"867_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jped.2016.05.007","volume":"93","author":"FA Motta","year":"2017","unstructured":"Motta FA, Dalla-Costa LM, Muro MD, Cardoso MN, Picharski GL, Jaeger G, et al. Risk factors for candidemia mortality in hospitalized children. J Pediatr. 2017;93(2):165\u201371. https:\/\/doi.org\/10.1016\/j.jped.2016.05.007.","journal-title":"J Pediatr"},{"issue":"1","key":"867_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/myc.12695","volume":"61","author":"HMS Canela","year":"2018","unstructured":"Canela HMS, Cardoso B, Vitali LH, Coelho HC, Martinez R, Ferreira MEdS. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil. Mycoses. 2018;61(1):11\u201321. https:\/\/doi.org\/10.1111\/myc.12695.","journal-title":"Mycoses"},{"issue":"4","key":"867_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bjid.2018.07.008","volume":"22","author":"PR Braga","year":"2018","unstructured":"Braga PR, Cruz IL, Ortiz I, Barreiros G, Nou\u00e9r SA, Nucci M. Secular trends of candidemia at a Brazilian tertiary care teaching hospital. Braz J Infect Dis. 2018;22(4):273\u20137. https:\/\/doi.org\/10.1016\/j.bjid.2018.07.008.","journal-title":"Braz J Infect Dis"},{"key":"867_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3094-9","author":"TA Marins","year":"2018","unstructured":"Marins TA, Marra AR, Edmond MB, Martino MDV, Yokota PKO, Mafra ACCN, et al. Evaluation of Candida bloodstream infection and antifungal utilization in a tertiary care hospital. BMC Infect Dis. 2018. https:\/\/doi.org\/10.1186\/s12879-018-3094-9.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"867_CR38","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/mmy\/myx077","volume":"56","author":"GL Breda","year":"2018","unstructured":"Breda GL, Tuon FF, Meis JF, Herkert PF, Hagen F, de Oliveira LZ, et al. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: a 5-year retrospective study. Med Mycol. 2018;56(4):406\u201315. https:\/\/doi.org\/10.1093\/mmy\/myx077.","journal-title":"Med Mycol"},{"issue":"2","key":"867_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.mycmed.2019.02.002","volume":"29","author":"AP Vieira De Melo","year":"2019","unstructured":"Vieira De Melo AP, Zuza-Alves DL, Da Silva-Rocha WP, de Ferreira Canario Souza LB, Francisco EC, de Salles Azevedo Melo A, et al. Virulence factors of Candida spp. obtained from blood cultures of patients with candidemia attended at tertiary hospitals in Northeast Brazil. J Mycol M\u00e9d. 2019;29(2):132\u20139. https:\/\/doi.org\/10.1016\/j.mycmed.2019.02.002.","journal-title":"J Mycol M\u00e9d"},{"issue":"23","key":"867_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015933","volume":"98","author":"LS Rodrigues","year":"2019","unstructured":"Rodrigues LS, Motta FA, Picharski GL, Vasconcelos TM, Riccieri MC, Dalla-Costa LM. Invasive candidiasis: risk factor for mortality in a pediatric tertiary care hospital in south of Brazil. Medicine. 2019;98(23): e15933.","journal-title":"Medicine"},{"issue":"8","key":"867_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221033","volume":"14","author":"MAPD Medeiros","year":"2019","unstructured":"Medeiros MAPD, Melo APVD, Bento ADO, Souza LBFCD, Neto FDAB, Garcia JB-L, et al. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: a six-year retrospective study. PLoS ONE. 2019;14(8): e0221033. https:\/\/doi.org\/10.1371\/journal.pone.0221033.","journal-title":"PLoS ONE"},{"issue":"8","key":"867_CR42","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/myc.13106","volume":"63","author":"AM da Paixao Sousa Silva","year":"2020","unstructured":"da Paixao Sousa Silva AM, de Moraes-Pinto MI, Teofilo Pignati L, Barbosa Teixeira B, Cordeiro Lima AP, Costa Pimentel Germano P, et al. Candida spp bloodstream infections in a Latin American pediatric oncology reference center epidemiology and associated factors. Mycoses. 2020;63(8):812\u201322. https:\/\/doi.org\/10.1111\/myc.13106.","journal-title":"Mycoses"},{"key":"867_CR43","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0206-2019","author":"PGV Alves","year":"2020","unstructured":"Alves PGV, Melo SGO, Bessa MADS, Brito MDO, Menezes RDP, Ara\u00fajo LBD, et al. Risk factors associated with mortality among patients who had candidemia in a university hospital. Rev Soc Bras Med Trop. 2020. https:\/\/doi.org\/10.1590\/0037-8682-0206-2019.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"867_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2020.11.006","volume":"25","author":"CS De Oliveira","year":"2021","unstructured":"De Oliveira CS, Colombo AL, Francisco EC, De Lima B, Gandra RF, De Carvalho MCP, et al. Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia network. Braz J Infect Dis. 2021;25(1): 101041. https:\/\/doi.org\/10.1016\/j.bjid.2020.11.006.","journal-title":"Braz J Infect Dis"},{"key":"867_CR45","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2020e10928","author":"DKB Rodrigues","year":"2021","unstructured":"Rodrigues DKB, Bonfietti LX, Garcia RA, Araujo MR, Rodrigues JS, Gimenes VMF, et al. Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of S\u00e3o Paulo State, Brazil. Braz J Med Biol Res. 2021. https:\/\/doi.org\/10.1590\/1414-431x2020e10928.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"867_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1590\/1806-93042021000200011","volume":"21","author":"HYW Silva","year":"2021","unstructured":"Silva HYW, Freitas FTDM. Invasive candidiasis in a Brazilian neonatal intensive care unit. Rev Bras Sa\u00fade Matern Infant. 2021;21(2):547\u201352. https:\/\/doi.org\/10.1590\/1806-93042021000200011.","journal-title":"Rev Bras Sa\u00fade Matern Infant"},{"issue":"2","key":"867_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s42770-023-00943-1","volume":"54","author":"CM da Silva","year":"2023","unstructured":"da Silva CM, de Carvalho AMR, Mac\u00eado DPC, Juc\u00e1 MB, Amorim RdJM, Neves RP. Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance. Braz J Microbiol. 2023;54(2):817\u201325. https:\/\/doi.org\/10.1007\/s42770-023-00943-1.","journal-title":"Braz J Microbiol"},{"issue":"3","key":"867_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/myc.12427","volume":"59","author":"J Giacomazzi","year":"2016","unstructured":"Giacomazzi J, Baethgen L, Carneiro LC, Millington MA, Denning DW, Colombo AL, et al. The burden of serious human fungal infections in Brazil. Mycoses. 2016;59(3):145\u201350. https:\/\/doi.org\/10.1111\/myc.12427.","journal-title":"Mycoses"},{"key":"867_CR49","doi-asserted-by":"crossref","unstructured":"Santos UPd. Spatial distribution of the Brazilian national system of innovation: an analysis for the 2000s. CEPAL Rev. 2017(122):2017\u20132234","DOI":"10.18356\/751f2336-en"},{"issue":"1","key":"867_CR50","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/s2666-5247(22)00261-0","volume":"4","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Hoenigl M, Gangneux J-P, Segal E, Alastruey-Izquierdo A, Arikan Akdagli S, et al. The current state of laboratory mycology and access to antifungal treatment in Europe: a European confederation of medical mycology survey. Lan Microbe. 2023;4(1):e47\u201356. https:\/\/doi.org\/10.1016\/s2666-5247(22)00261-0.","journal-title":"Lan Microbe"},{"issue":"3","key":"867_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106718","volume":"61","author":"J Salmanton-Garc\u00eda","year":"2023","unstructured":"Salmanton-Garc\u00eda J, Au W-Y, Hoenigl M, Chai LYA, Badali H, Basher A, et al. The current state of laboratory mycology in Asia\/Pacific: a survey from the European confederation of medical mycology (ECMM) and international society for human and animal mycology (ISHAM). Int J Antimicrob Agents. 2023;61(3): 106718. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106718.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"867_CR52","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1016\/S2666-5247(21)00190-7","volume":"3","author":"C Driemeyer","year":"2022","unstructured":"Driemeyer C, Falci DR, Oladele RO, Bongomin F, Ocansey BK, Govender NP, et al. The current state of clinical mycology in Africa: a European confederation of medical mycology and international society for human and animal mycology survey. Lan Microbe. 2022;3(6):e464\u201370. https:\/\/doi.org\/10.1016\/S2666-5247(21)00190-7.","journal-title":"Lan Microbe"},{"key":"867_CR53","unstructured":"Sa\u00fade SdVeS-Md. PORTARIA N\u00ba 64, DE 11 DE DEZEMBRO DE 2018. In: Sa\u00fade SdVe, editor. Bras\u00edlia2018"},{"issue":"1","key":"867_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146909","volume":"11","author":"AM Doi","year":"2016","unstructured":"Doi AM, Pignatari ACC, Edmond MB, Marra AR, Camargo LFA, Siqueira RA, et al. Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program. PLoS ONE. 2016;11(1): e0146909. https:\/\/doi.org\/10.1371\/journal.pone.0146909.","journal-title":"PLoS ONE"},{"key":"867_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jof3020024","author":"DA da Matta","year":"2017","unstructured":"da Matta DA, Souza ACR, Colombo AL. Revisiting species distribution and antifungal susceptibility of Candida bloodstream isolates from Latin American medical centers. J Fungi. 2017. https:\/\/doi.org\/10.3390\/jof3020024.","journal-title":"J Fungi"},{"key":"867_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz573","author":"M Xiao","year":"2020","unstructured":"Xiao M, Chen SCA, Kong F, Xu X-L, Yan L, Kong H-S, et al. Distribution and antifungal susceptibility of Candida species causing candidemia in China: an update from the CHIF-NET study. J Infect Dis. 2020. https:\/\/doi.org\/10.1093\/infdis\/jiz573.","journal-title":"J Infect Dis"},{"key":"867_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100117","volume":"6","author":"C Agnelli","year":"2022","unstructured":"Agnelli C, Valerio M, Bouza E, Guinea J, Sukiennik T, Guimar\u00e3es T, et al. Prognostic factors of Candida spp bloodstream infection in adults: a nine-year retrospective cohort study across tertiary hospitals in Brazil and Spain. Lancet Reg Health Am. 2022;6: 100117. https:\/\/doi.org\/10.1016\/j.lana.2021.100117.","journal-title":"Lancet Reg Health Am"},{"key":"867_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11090963","author":"S Kumar","year":"2022","unstructured":"Kumar S, Kumar A, Roudbary M, Mohammadi R, \u010cern\u00e1kov\u00e1 L, Rodrigues CF. Overview on the infections related to rare Candida species. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11090963.","journal-title":"Pathogens"},{"key":"867_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myad010","author":"A Cook","year":"2023","unstructured":"Cook A, Ferreras-Antolin L, Adhisivam B, Ballot D, Berkley JA, Bernaschi P, et al. Neonatal invasive candidiasis in low- and middle-income countries: data from the NeoOBS study. Med Mycol. 2023. https:\/\/doi.org\/10.1093\/mmy\/myad010.","journal-title":"Med Mycol"},{"issue":"2","key":"867_CR60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.riam.2016.06.008","volume":"34","author":"DdSOd Alencar","year":"2017","unstructured":"Alencar DdSOd, Tsujisaki RAdS, Spositto FLE, Nunes MdO, Almeida AAd, Martins MdA, et al. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: clinical characteristics and antifungal susceptibility profile. Rev Iberoam Micol. 2017;34(2):106\u20138. https:\/\/doi.org\/10.1016\/j.riam.2016.06.008.","journal-title":"Rev Iberoam Micol"},{"key":"867_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/jof8020100","author":"DY Thomaz","year":"2022","unstructured":"Thomaz DY, Del Negro GMB, Ribeiro LB, da Silva M, Carvalho GOMH, Camargo CH, et al. A Brazilian inter-hospital Candidemia outbreak caused by fluconazole-resistant Candida parapsilosis in the COVID-19 era. J Fungi. 2022. https:\/\/doi.org\/10.3390\/jof8020100.","journal-title":"J Fungi"},{"issue":"8","key":"867_CR62","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ijmm.2015.08.003","volume":"305","author":"M Ziccardi","year":"2015","unstructured":"Ziccardi M, Souza LOP, Gandra RM, Galdino ACM, Baptista ARS, Nunes APF, et al. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: species distribution, antifungal susceptibility and virulence attributes. Int J Med Microbiol. 2015;305(8):848\u201359. https:\/\/doi.org\/10.1016\/j.ijmm.2015.08.003.","journal-title":"Int J Med Microbiol"},{"key":"867_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/ffunb.2022.957021","author":"R Lima","year":"2022","unstructured":"Lima R, Ribeiro FC, Colombo AL, De Almeida JN. The emerging threat antifungal-resistant Candida tropicalis in humans, animals, and environment. Front Fungal Biol. 2022. https:\/\/doi.org\/10.3389\/ffunb.2022.957021.","journal-title":"Front Fungal Biol"},{"key":"867_CR64","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jgar.2021.03.018","volume":"25","author":"LM Favarello","year":"2021","unstructured":"Favarello LM, Nucci M, Queiroz-Telles F, Guimaraes T, Salles MJ, Sukiennik TCT, et al. Trends towards lower azole susceptibility among 200 Candida tropicalis bloodstream isolates from Brazilian medical centres. J Glob Antimicrob Resist. 2021;25:199\u2013201. https:\/\/doi.org\/10.1016\/j.jgar.2021.03.018.","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"867_CR65","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/myc.12469","volume":"59","author":"SS Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves SS, Souza ACR, Chowdhary A, Meis JF, Colombo AL. Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses. 2016;59(4):198\u2013219. https:\/\/doi.org\/10.1111\/myc.12469.","journal-title":"Mycoses"},{"issue":"2","key":"867_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5863\/1551-6776-26.2.115","volume":"26","author":"CD Hornik","year":"2021","unstructured":"Hornik CD, Bondi DS, Greene NM, Cober MP, John B. Review of fluconazole treatment and prophylaxis for invasive candidiasis in neonates. J Pediatr Pharmacol Ther. 2021;26(2):115\u201322. https:\/\/doi.org\/10.5863\/1551-6776-26.2.115.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"867_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/jof7020093","author":"K Spettel","year":"2021","unstructured":"Spettel K, Galazka S, Kriz R, Camp I, Willinger B. Do Candida albicans isolates with borderline resistant micafungin MICs always harbor FKS1 hot spot mutations? J Fungi. 2021. https:\/\/doi.org\/10.3390\/jof7020093.","journal-title":"J Fungi"},{"key":"867_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/jof9020207","author":"B Spruijtenburg","year":"2023","unstructured":"Spruijtenburg B, Baqueiro CCSZ, Colombo AL, Meijer EFJ, de Almeida JN, Berrio I, et al. Short tandem repeat genotyping and antifungal susceptibility testing of Latin American Candida tropicalis Isolates. J Fungi. 2023. https:\/\/doi.org\/10.3390\/jof9020207.","journal-title":"J Fungi"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-024-00867-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00867-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:16:08Z","timestamp":1724415368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-024-00867-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["867"],"URL":"https:\/\/doi.org\/10.1007\/s11046-024-00867-w","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FGH declares no competing interests, ACG has recently received research funding and\/or consultation fees from bioMerieux Eurofarma, MSD, Pfizer, Roche, Sandoz, Uni\u00e3o Qu\u00edmica, and United Medical. ALC has received educational grants from Eurofarma, Biotoscana-Knight, United Medical-Knight, Gilead, Sandoz, Mundipharma and Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is a systematic review, and so, the institutional ethics review board has confirmed that no ethics approval is needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"60"}}